TriSalus Life Sciences (TLSI) Income from Continuing Operations (2021 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly Income from Continuing Operations of 1539000.0 for Q1 2026, up 114.83% year-over-year from 716367.94 in Q1 2025, and up 115.78% quarter-over-quarter from 9753000.0 in Q4 2025.
TriSalus Life Sciences (TLSI) Income from Continuing Operations (2021 - 2026) Analysis & Trends
TriSalus Life Sciences' Income from Continuing Operations history runs 6 years deep, the most recent figure standing at 1539000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 114.83% year-over-year to 1539000.0; the TTM figure through Mar 2026 stood at 27313000.0 (changed 0.36% YoY), while the FY2025 annual figure was 39227000.0, down 30.56% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 1539000.0, up from 9753000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 2836725.0 in Q1 2022, with the low at 35639000.0 in Q4 2023.
- The 5-year median for Income from Continuing Operations is 8288000.0 (2025), against an average of 8967708.0.
- Peak annual rise in Income from Continuing Operations reached 958.66% in 2022, while the deepest fall reached 878.46% in 2022.
- TriSalus Life Sciences' Income from Continuing Operations stood at 22542000.0 in 2022, then tumbled by 58.1% to 35639000.0 in 2023, then soared by 71.64% to 10108000.0 in 2024, then gained by 3.51% to 9753000.0 in 2025, then surged by 115.78% to 1539000.0 in 2026.
- Business Quant data shows TLSI's Income from Continuing Operations at 1539000.0 in Q1 2026, 9753000.0 in Q4 2025, and 10811000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 201.00 Mn |
| 10 | TriSalus Life Sciences | 306.06 Mn | 259.77 Mn | 9.90 Mn | -9.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.19 Mn |
| Mar 31, 2026 | 1.54 Mn |
| Dec 31, 2025 | -9.75 Mn |
| Sep 30, 2025 | -10.81 Mn |
| Jun 30, 2025 | -8.29 Mn |
| Mar 31, 2025 | -10.38 Mn |
| Dec 31, 2024 | -10.11 Mn |
| Sep 30, 2024 | -2.40 Mn |
| Jun 30, 2024 | -4.33 Mn |
| Mar 31, 2024 | -13.21 Mn |
| Dec 31, 2023 | -35.64 Mn |
| Sep 30, 2023 | -1.43 Mn |
| Jun 30, 2023 | -13.97 Mn |
| Mar 31, 2023 | -8.27 Mn |
| Dec 31, 2022 | -22.54 Mn |
| Sep 30, 2022 | -8.09 Mn |
| Jun 30, 2022 | 2.39 Mn |
| Mar 31, 2022 | 2.84 Mn |
| Dec 31, 2021 | 2.90 Mn |
| Sep 30, 2021 | 1.86 Mn |